MEDVi Review: AI-Powered GLP-1 With Personalized Dosing
An AI-powered weight management platform that uses artificial intelligence to optimize your GLP-1 treatment. Semaglutide from $129/mo, tirzepatide from $219/mo.
Our Rating
4.2 / 5.0
Semaglutide From
$129/month
Tirzepatide From
$219/month
Technology
AI-Powered Dosing
Physicians
Obesity Medicine
Tracking
Body Composition + AI
Shipping
Free
States
44+
What Is MEDVi?
MEDVi is an AI-powered telehealth platform designed for personalized weight management. Unlike traditional GLP-1 providers that follow standard dosing protocols, MEDVi uses proprietary artificial intelligence technology to analyze patient data and create personalized treatment recommendations tailored to each individual.
The platform offers compounded semaglutide starting at $129/month and tirzepatide from $219/month, with all prescriptions managed by board-certified obesity medicine physicians. MEDVi's AI-driven approach extends beyond prescribing — it continuously tracks your progress, optimizes dosing, and provides personalized meal suggestions based on your data.
Available in 44+ states, MEDVi combines modern app-based tracking with regular provider check-ins enhanced by AI insights. The platform includes body composition tracking, progress visualization dashboards, and free shipping on all medications with no long-term contracts required.
Medications & Pricing
MEDVi offers two primary compounded GLP-1 medications with AI-optimized dosing protocols:
Semaglutide
Most PopularCompounded GLP-1 receptor agonist
- ✓Starting at $129/month
- ✓AI-optimized dosing
- ✓Free shipping
- ✓Body composition tracking
Tirzepatide
Best ResultsDual-action GLP-1 + GIP medication
- ✓Starting at $219/month
- ✓Dual-action GLP-1+GIP
- ✓AI-driven dose adjustments
- ✓Progress visualization
How It Works
Complete Your AI Health Profile
Fill out a comprehensive health intake that feeds into MEDVi's AI engine. The system analyzes your medical history, lifestyle, and goals to recommend a personalized treatment plan.
Physician Review & AI-Optimized Prescription
A board-certified obesity medicine physician reviews your profile alongside the AI's recommendations. Your personalized dosing protocol is created based on both clinical expertise and data-driven insights.
Track, Optimize & Adjust
Your medication ships free to your door. Use the MEDVi app to track body composition, view progress dashboards, and receive AI-generated meal suggestions. The AI continuously analyzes your data to optimize dosing at each check-in.
AI-Powered Approach
MEDVi's core differentiator is its proprietary AI technology that analyzes patient data for personalized recommendations. Rather than following a one-size-fits-all dosing schedule, the AI engine considers your individual response patterns, body composition changes, and progress trajectory to suggest dose adjustments.
The platform's AI also powers personalized meal suggestions based on your data, helping patients align their nutrition with their treatment. Regular provider check-ins are enhanced by AI insights, giving physicians a data-rich picture of each patient's progress before making clinical decisions.
The modern app includes a dashboard for progress visualization, body composition tracking, and AI-driven recommendations — making the treatment experience feel more like a tech product than a traditional medical service. It's worth noting, however, that the effectiveness of MEDVi's AI technology has not been independently verified or peer-reviewed.
Pros & Cons
Pros
- ✓AI-powered dosing optimization — genuinely innovative
- ✓Board-certified obesity medicine physicians
- ✓Both semaglutide and tirzepatide available
- ✓Body composition tracking through the app
- ✓AI-driven progress insights and recommendations
- ✓Free shipping included
- ✓Personalized meal suggestions
- ✓Modern app with progress dashboard
- ✓No long-term contracts
Cons
- ✗Higher pricing than budget GLP-1 providers
- ✗AI technology effectiveness not independently verified
- ✗Available in 44+ states (not all 50)
- ✗Newer platform with less long-term track record
- ✗No community or peer support features
- ✗No brand-name GLP-1 options
- ✗AI features may feel impersonal to some patients
Who Is MEDVi For?
MEDVi is ideal if:
- •You're a tech-savvy patient who wants AI-driven treatment optimization
- •You value data-driven, personalized dosing protocols
- •You enjoy tracking progress through app dashboards
- •You want obesity medicine specialists with AI enhancement
- •You're willing to pay more for cutting-edge technology in your treatment
Our Verdict
MEDVi brings genuine innovation to GLP-1 treatment with its AI-powered dosing optimization and progress tracking. The combination of board-certified obesity medicine physicians with AI-driven insights is a compelling differentiator that sets it apart from more traditional telehealth providers. The app experience and body composition tracking add meaningful value to the treatment journey.
However, at $129/month for semaglutide, MEDVi is pricier than CoreAge Rx at $99/mo. MEDVi is ideal for tech-forward patients who want data-driven optimization and are willing to pay a premium for AI-enhanced care. For those seeking straightforward value without the AI bells and whistles, CoreAge Rx remains our top pick.
Try MEDVi
AI-powered GLP-1 treatment. Semaglutide from $129/mo, tirzepatide from $219/mo.
Disclosure: This article contains affiliate links. If you sign up through our links, we may receive a commission at no additional cost to you. This does not influence our editorial recommendations. Always consult your healthcare provider before starting any medication.
Compare the Top GLP-1 Providers
See how MEDVi compares to our other top-rated GLP-1 providers.